Paper Details

  1. Home
  2. Paper Details

The course of COVID-19 in patients with severe asthma receiving biological treatment.

Author: CakmakMehmet Erdem, Can BostanOzge, DamadogluEbru, KalyoncuAli Fuat, KarakayaGül, KayaSaltuk Bugra, TuncayGülseren

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study aimed to demonstrate the clinical course of COVID-19 in severe asthmatic patients receiving biological treatment. The study highlights the importance of continuing biological therapy during the pandemic to decrease corticosteroid use and prevent exacerbations.
Paper Details　
Original Abstract of the Article :
In order to decrease the use of systemic corticosteroids and prevent asthma exacerbations, EAACI and GINA made recommendations in favor of severe asthma patients continuing the use of biologicals during the pandemic. However, the course of SARS-CoV-2 infection remains uncertain, especially in patien...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/02770903.2021.1996599

データ提供：米国国立医学図書館（NLM）

COVID-19 in Severe Asthma Patients on Biological Treatment: A Study

The COVID-19 pandemic posed unique challenges for individuals with chronic conditions like severe asthma, raising concerns about the impact of the virus on their health. This study, published in 2020, aimed to investigate the course of COVID-19 in severe asthma patients receiving biological treatment, a type of medication that helps control inflammation and improve lung function. The researchers examined the clinical course of COVID-19 in these patients, seeking to understand the potential effects of biological therapy on the severity and outcomes of infection. Their findings provided valuable insights into the management of COVID-19 in this patient population.

Biological Treatment and COVID-19: A Look at Asthma Patients

This study investigates the course of COVID-19 in severe asthma patients receiving biological treatment, a type of medication commonly used to manage severe asthma. The study sheds light on the potential impact of biological therapy on the severity and outcomes of COVID-19 in this patient population, providing valuable insights for clinicians managing this challenging condition.

Managing COVID-19 in Severe Asthma: A Complex Landscape

This research highlights the complex interplay between severe asthma, biological treatment, and COVID-19. The study underscores the need for careful monitoring and individualized management approaches for patients with severe asthma who contract COVID-19, taking into account the potential impact of biological therapy on disease progression and outcomes.

Dr. Camel's Conclusion

Just as a camel navigates the shifting sands of a desert, clinicians must carefully navigate the complex landscape of severe asthma, biological treatment, and COVID-19. This study provides valuable insights into the management of COVID-19 in this patient population, highlighting the need for individualized approaches and close monitoring.

Date :
  1. Date Completed 2022-10-19
  2. Date Revised 2022-12-22
Further Info :

Pubmed ID

34669544

DOI: Digital Object Identifier

10.1080/02770903.2021.1996599

Related Literature

Article Analysis
・Effects of mepolizumab injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.